Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuriko Shimizu
Long-Term Mood/Antidepressant Effects of Quetiapine Extended-Release Formulation: An Open-Label, Non-Controlled Extension Study in Japanese Patients With Bipolar Depression
BMC Psychiatry
Psychiatry
Mental Health
Related publications
The Efficacy and Safety of Once-Daily Quetiapine Extended Release in Patients With Schizophrenia Switched From Other Antipsychotics: An Open-Label Study in Chinese Population
BMC Psychiatry
Psychiatry
Mental Health
Long-Term Metformin Treatment in Adolescents With Obesity and Insulin Resistance, Results of an Open Label Extension Study
Nutrition and Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
SAT0236 Long-Term Safety and Efficacy of Upadacitinib (ABT-494), an Oral Jak-1 Inhibitor in Patients With Rheumatoid Arthritis in an Open Label Extension Study
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients With Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
An Open-Label, Prospective Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Long-Term Treatment of Refractory Depression
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Ziprasidone in Adolescents With Schizophrenia: Results From a Placebo-Controlled Efficacy and Long-Term Open-Extension Study
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Long-Term Safety of Siltuximab in Patients With Idiopathic Multicentric Castleman Disease: A Prespecified, Open-Label, Extension Analysis of Two Trials
The Lancet Haematology
Hematology
Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
